Norbrook Laboratories Ltd has launched Propentofylline, a new product designed to reduce lethargy and improve general demeanour and exercise tolerance in older dogs.  

Michelle Jones, Brand Manager at Norbrook said: "We launched Propentofylline to the UK market at the recent VPMA Congress where it was warmly received by the delegates with plenty of positive comments on both the lively design of the campaign and the opportunities for use of this product in practice. The product is indicated for improving dullness, lethargy and general demeanour in dogs to essentially give them a new lease of life."

Available in 50mg and 100mg tablets, Norbrook says Propentofylline can be prescribed to help boost a dog's willingness to exercise and improve exercise tolerance.

Speaking at the launch of the product at the VPMA Congress, Ms Pauline Graham, VPMA President from Capontree Vets said: "Propentofylline, as an active ingredient, is widely prescribed by vets with its properties that assist increased blood flow, particularly to the heart and skeletal muscle. Also increasing the blood flow to the brain and therefore its oxygen supply, it is a well recognised treatment for older, lethargic dogs to help encourage brightness as well as tolerance and willingness to exercise.  I am pleased to see Norbrook offering this product as another high quality and cost-effective addition to their small animal range."

Michelle added: "Veterinary practices can avail themselves of a range of promotional support material for our Propentofylline product including a technical brochure and waiting room posters. We will also have an introductory offer which our Territory Managers will be pleased to discuss with their clients."

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.